Ginkgo Bioworks Receives $100,000,000 Series C Round

  • Feed Type
  • Date
    6/8/2016
  • Company Name
    Ginkgo Bioworks
  • Mailing Address
    27 Drydock Ave. 8th Floor Boston, MA 02210 USA
  • Company Description
    Ginkgo Bioworks is the organism company. We design custom microbes for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.
  • Website
    http://www.ginkgobioworks.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $100,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The new funds will be used to help fuel the company’s growth into new markets, such as commodity chemicals, industrial enzymes and human health markets, as well as to build its next-generation automated foundry, Bioworks2, where Ginkgo’s organism engineers can develop new designs at massive scale.
  • M&A Terms
  • Venture Investor
    Y Combinator
  • Venture Investor
    Senator Investment Group
  • Venture Investor
    Baillie Gifford
  • Venture Investor
    Viking Global Investors
  • Venture Investor
    Allen & Company

Trending on Xconomy